Estrella Immunopharma, Inc. (ESLA)
1.58
-0.13
(-7.60%)
USD |
NASDAQ |
Apr 24, 16:00
1.60
+0.02
(+1.27%)
After-Hours: 20:00
Estrella Immunopharma Shareholders Equity (Quarterly) : -10.37M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.70B |
| Arcellx, Inc. | 402.35M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Agenus, Inc. | -271.11M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.177M |
| Total Liabilities (Quarterly) | 13.54M |
| Current Ratio | 0.1238 |